BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33711763)

  • 1. An original pronucleotide strategy for the simultaneous delivery of two bioactive drugs.
    Villard AL; Aubertin AM; Peyrottes S; Périgaud C
    Eur J Med Chem; 2021 Apr; 216():113315. PubMed ID: 33711763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mononucleoside phosphorodithiolates as mononucleotide prodrugs.
    Schlienger N; Lefebvre I; Aubertin AM; Peyrottes S; Périgaud C
    Eur J Med Chem; 2022 Jan; 227():113914. PubMed ID: 34695774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic phosphoramidates as antiviral pronucleotides.
    Zemlicka J
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):276-86. PubMed ID: 12084469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A step further in the SATE mononucleotide prodrug approach.
    Peyrottes S; Villard AL; Coussot G; Augustijns P; Lefebvre I; Aubertin AM; Gosselin G; Périgaud C
    Nucleic Acids Symp Ser (Oxf); 2008; (52):539-40. PubMed ID: 18776492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SATE pronucleotide approaches: an overview.
    Peyrottes S; Egron D; Lefebvre I; Gosselin G; Imbach JL; Périgaud C
    Mini Rev Med Chem; 2004 May; 4(4):395-408. PubMed ID: 15134542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing a pronucleotide stratagem: lessons from amino acid phosphoramidates of anticancer and antiviral pyrimidines.
    Drontle DP; Wagner CR
    Mini Rev Med Chem; 2004 May; 4(4):409-19. PubMed ID: 15134543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, stability, and biological evaluation of 1,3-dihydrobenzo[c]furan analogue of d4T and its SATE pronucleotide.
    Len C; Selouane A; Postel D; Villa P; Aubertin AM; Egron D; Gosselin G; Périgaud C
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):943-5. PubMed ID: 14565317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cycloSal-pronucleotides design of chemical trojan horses.
    Meier C
    Mini Rev Med Chem; 2002 Jun; 2(3):219-34. PubMed ID: 12370064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules.
    Meier C; Balzarini J
    Antiviral Res; 2006 Sep; 71(2-3):282-92. PubMed ID: 16735066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorodiamides as prodrugs for antiviral nucleosides.
    Shipitsyn AV; Zakirova NF; Belanov EF; Pronyaeva TR; Fedyuk NV; Kukhanova MK; Pokrovsky AG
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):963-6. PubMed ID: 14565322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.
    Wagner CR; Iyer VV; McIntee EJ
    Med Res Rev; 2000 Nov; 20(6):417-51. PubMed ID: 11058891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugs.
    Egron D; Imbach JL; Gosselin G; Aubertin AM; Périgaud C
    J Med Chem; 2003 Oct; 46(21):4564-71. PubMed ID: 14521418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs of Nucleoside 5'-Monophosphate Analogues: Overview of the Recent Literature Concerning their Synthesis and Applications.
    Roy B; Navarro V; Peyrottes S
    Curr Med Chem; 2023; 30(11):1256-1303. PubMed ID: 36093825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.
    Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL
    Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
    Egron D; Arzumanov AA; Dyatkina NB; Aubertin AM; Imbach JL; Gosselin G; Krayevsky A; Périgaud C
    Bioorg Chem; 2001 Dec; 29(6):333-44. PubMed ID: 11846432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV-Active Nucleoside Triphosphate Prodrugs.
    Jia X; Schols D; Meier C
    J Med Chem; 2020 Jun; 63(11):6003-6027. PubMed ID: 32421343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular trapping of cycloSal-pronucleotides: modification of prodrugs with amino acid esters.
    Jessen HJ; Balzarini J; Meier C
    J Med Chem; 2008 Oct; 51(20):6592-8. PubMed ID: 18826203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Lock-in"-cycloSal-pronucleotides - a new generation of chemical Trojan Horses?
    Meier C; Ruppel MF; Vukadinovic D; Balzarini J
    Mini Rev Med Chem; 2004 May; 4(4):383-94. PubMed ID: 15134541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cycloSal-d4TMP pronucleotides structural variations, mechanistic insights and antiviral activity.
    Meiera C; Renzea J; Ducho C; Balzarini J
    Curr Top Med Chem; 2002 Oct; 2(10):1111-21. PubMed ID: 12173970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ProTides Boom.
    Mehellou Y
    ChemMedChem; 2016 Jun; 11(11):1114-6. PubMed ID: 27159529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.